Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Risks of blood transfusion.

Lawrence T Goodnough1

  • 1Department of Pathology, Stanford University School of Medicine, 300 Pasteur Drive, H-1402 Stanford, CA 94305-5324, USA. ltgoodno@stanford.edu

Anesthesiology Clinics of North America
|June 1, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Authors' Reply to Michael Auerbach's Comment on: "Frequency and Associated Costs of Anaphylaxis- and Hypersensitivity-Related Adverse Events for Intravenous Iron Products in the USA: An Analysis Using the US Food and Drug Administration Adverse Event Reporting System".

Drug safety·2021
Same author

Parenteral iron therapy and phosphorus homeostasis: A review.

American journal of hematology·2021
Same author

Frequency and Associated Costs of Anaphylaxis- and Hypersensitivity-Related Adverse Events for Intravenous Iron Products in the USA: An Analysis Using the US Food and Drug Administration Adverse Event Reporting System.

Drug safety·2020
Same author

Iron Administration, Infection, and Anemia Management in CKD: Untangling the Effects of Intravenous Iron Therapy on Immunity and Infection Risk.

Kidney medicine·2020
Same author

How I treat anemia in the perisurgical setting.

Blood·2020
Same author

Establishing a Satellite Transfusion Service Within an Academic Medical Center.

American journal of clinical pathology·2020

Blood safety has advanced significantly over 20 years, focusing on preventing viral infections. Proactive strategies and pathogen inactivation technologies are crucial for managing emerging threats and ensuring transfusion safety.

Area of Science:

  • Medical Science
  • Infectious Diseases
  • Public Health

Background:

  • Blood transfusion safety has seen major improvements over the past two decades.
  • Key risks include administrative errors, transfusion-related acute lung injury, and bacterial contamination.
  • Emerging pathogens like West Nile virus highlight ongoing safety challenges.

Purpose of the Study:

  • To review advancements in blood safety over the last 20 years.
  • To emphasize the importance of preventing transfusion-transmitted viral infections.
  • To discuss strategies for mitigating emerging infectious risks in blood products.

Main Methods:

  • Review of scientific literature and public health data.
  • Analysis of trends in transfusion safety measures.

Related Experiment Videos

  • Evaluation of pathogen inactivation technologies and nucleic acid testing.

    • Main Results:

    • Significant progress has been made in reducing transfusion-transmitted viral infections.
    • Administrative errors and bacterial contamination remain critical safety concerns.
    • Proactive strategies are essential for addressing novel and emerging pathogens.

    Conclusions:

    • Continued vigilance and implementation of advanced technologies are vital for blood safety.
    • Pathogen inactivation and nucleic acid testing are key to ensuring safe blood transfusions.
    • A multi-faceted approach is necessary to address the evolving landscape of transfusion risks.